Ryuichi Iwakiri

6.8k total citations
169 papers, 4.2k citations indexed

About

Ryuichi Iwakiri is a scholar working on Surgery, Gastroenterology and Molecular Biology. According to data from OpenAlex, Ryuichi Iwakiri has authored 169 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Surgery, 62 papers in Gastroenterology and 32 papers in Molecular Biology. Recurrent topics in Ryuichi Iwakiri's work include Gastroesophageal reflux and treatments (36 papers), Helicobacter pylori-related gastroenterology studies (34 papers) and Eosinophilic Esophagitis (24 papers). Ryuichi Iwakiri is often cited by papers focused on Gastroesophageal reflux and treatments (36 papers), Helicobacter pylori-related gastroenterology studies (34 papers) and Eosinophilic Esophagitis (24 papers). Ryuichi Iwakiri collaborates with scholars based in Japan, United States and South Korea. Ryuichi Iwakiri's co-authors include Kazuma Fujimoto, Seiji Tsunada, Hiroyuki Sakata, Yasuhisa Sakata, Takahiro Noda, Ryo Shimoda, Takehiro Fujise, Akifumi Ootani, Tak Yee Aw and Shinichi Ogata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cancer.

In The Last Decade

Ryuichi Iwakiri

168 papers receiving 4.1k citations

Peers

Ryuichi Iwakiri
Comparison fields: 5 of 126
  • Surgery 1.9k
  • Gastroenterology 1.5k
  • Pulmonary and Respiratory Medicine 1.1k
  • Epidemiology 657
  • Molecular Biology 531
Choitsu Sakamoto Japan
Masahiko Inamori Japan
Kazuma Fujimoto Japan
Hiroyuki Hanai Japan
Hideyuki Hiraishi Japan
Christos Zavos Greece
Woo Kyu Jeon South Korea
W. F. Caspary Germany
David L. Earnest United States
Hidekazu Suzuki Japan
Choitsu Sakamoto Japan View profile →
Citations per field, relative to Ryuichi Iwakiri
Ryuichi Iwakiri · 1×
Citations per year, relative to Ryuichi Iwakiri
Ryuichi Iwakiri · 1×

Countries citing papers authored by Ryuichi Iwakiri

Since Specialization
Citations

This map shows the geographic impact of Ryuichi Iwakiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Iwakiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Iwakiri more than expected).

Fields of papers citing papers by Ryuichi Iwakiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Iwakiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Iwakiri. The network helps show where Ryuichi Iwakiri may publish in the future.

Co-authorship network of co-authors of Ryuichi Iwakiri

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Iwakiri. A scholar is included among the top collaborators of Ryuichi Iwakiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Iwakiri. Ryuichi Iwakiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study Advances in Therapy Katsuyoshi Matsuoka, Tadakazu Hisamatsu et al. 1
2 A Computational Platform Integrating a Mechanistic Model of Crohn’s Disease for Predicting Temporal Progression of Mucosal Damage and Healing Advances in Therapy Ryuichi Iwakiri, Zhen Qi et al. 24
3 Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan PharmacoEconomics Luis Hernández, Heather Burnett et al. 11
4 Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis Digestion Satoko Yamasaki, Yasuhisa Sakata et al. 4
5 High Cost of Hospitalization for Colonic Diverticular Bleeding Depended on Repeated Bleeding and Blood Transfusion: Analysis with Diagnosis Procedure Combination Data in Japan Digestion Yoichiro Ito, Yasuhisa Sakata et al. 13
6 Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi‐centers with 185 patients Digestive Endoscopy Ryuichi Iwakiri, Kazuma Fujimoto et al. 6
7 Chemopreventive effect of mofezolac on beef tallow diet/azoxymethane-induced colon carcinogenesis in rats. PubMed Ryosuke Shiraishi, Takehiro Fujise et al. 2
8 Pyodermatitis–pyostomatitis vegetans after subtotal colectomy for ulcerative colitis The Journal of Dermatology Noriyuki Misago, Ryuichi Iwakiri et al. 11
9 ENDOSCOPIC HEMOSTASIS WITH METALLIC HEMOCLIPS FOR IATROGENIC MALLORY‐WEISS TEAR CAUSED BY ENDOSCOPIC EXAMINATION Digestive Endoscopy Ryo Shimoda, Ryuichi Iwakiri et al. 21
10 Case series of endoscopic balloon dilation to treat a stricture caused by circumferential resection of the gastric antrum by endoscopic submucosal dissection Gastrointestinal Endoscopy Seiji Tsunada, Shinichi Ogata et al. 47
11 Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review Journal of Gastroenterology Sadahiro Amemori, Ryuichi Iwakiri et al. 33
12 Apoptosis in rat jejunal mucosa is regulated partly through the central nervous system, which controls feeding behavior Journal of Gastroenterology and Hepatology Hiroyuki Sakata, Akifumi Ootani et al. 4
13 Chlamydia trachomatis proctitis Gastrointestinal Endoscopy Akifumi Ootani, Masanobu Mizuguchi et al. 13
14 Endoscopic injection sclerotherapy for esophageal varices in cirrhotic patients without hepatocellular carcinoma: a comparison of longterm survival between prophylactic therapy and emergency therapy Journal of Gastroenterology Ryuichi Iwakiri, Hiroyuki Sakata et al. 4
15 Endoscopic Injection Sclerotherapy for Esophageal Varices in Cirrhotic Patients With Hepatocellular Carcinoma Journal of Clinical Gastroenterology Keiji Matsunaga, Ryuichi Iwakiri et al. 7
16 Normalization of Phospholipids Concentration of the Gastric Mucosa was Observed in Patients with Peptic Ulcer after Eradication of Helicobacter pylori Helicobacter Ryuichi Iwakiri, Ryo Shimoda et al. 7
17 Histaminergic Effect on Apoptosis of Rat Small Intestinal Mucosa After Ischemia–Reperfusion Digestive Diseases and Sciences Ryuichi Iwakiri, Kazuyo Okamoto et al. 14
18 Ornithine decarboxylase activity in rat intestinal mucosa and liver is stimulated by central administration of 2-deoxy-d-glucose but not of 2,5-anhydro-d-mannitol Brain Research Kazuma Fujimoto, Toshiie Sakata et al. 8
19 Selective IgG deficiency with a transcriptional disorder of the γ switching region gene and the IL-4 gene International Immunology Hideo Kaneko, Manabu Nakashima et al. 1
20 Drug-induced allergic hepatitis caused by glycyrrhizin, or extract of licorice root. Kanzo Koichi Akashi, M Shirahama et al. 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026